GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSFF) » Definitions » Change In Receivables

OSSFF (Embla Medical hf) Change In Receivables : $-5.5 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf Change In Receivables?

Embla Medical hf's change in receivables for the quarter that ended in Dec. 2024 was $0.7 Mil. It means Embla Medical hf's Accounts Receivable declined by $0.7 Mil from Sep. 2024 to Dec. 2024 .

Embla Medical hf's change in receivables for the fiscal year that ended in Dec. 2024 was $-5.5 Mil. It means Embla Medical hf's Accounts Receivable increased by $5.5 Mil from Dec. 2023 to Dec. 2024 .

Embla Medical hf's Accounts Receivable for the quarter that ended in Dec. 2024 was $121.9 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Embla Medical hf's Days Sales Outstanding for the three months ended in Dec. 2024 was 49.49.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Embla Medical hf's liquidation value for the three months ended in Dec. 2024 was $-509.1 Mil.


Embla Medical hf Change In Receivables Historical Data

The historical data trend for Embla Medical hf's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Change In Receivables Chart

Embla Medical hf Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.45 -13.18 -13.20 -16.37 -5.52

Embla Medical hf Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.53 -4.82 -9.53 8.14 0.69

Embla Medical hf Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf  (OTCPK:OSSFF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Embla Medical hf's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=121.915/224.781*91
=49.49

2. In Ben Graham's calculation of liquidation value, Embla Medical hf's accounts receivable are only considered to be worth 75% of book value:

Embla Medical hf's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=86.163-758.266+0.75 * 121.915+0.5 * 143.102
=-509.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf Change In Receivables Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

From GuruFocus

Q3 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 02-06-2025

Q4 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Ossur hf Corporate Analyst Meeting Transcript

By GuruFocus Research 02-14-2024

Q1 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus Research 04-24-2024

Q2 2023 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 10-09-2024